Evidence map›Paper›PMID 24917498›Full record

ArticleDevelopment (Cambridge, England)2014

Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.

Dipankar J Dutta, Andleeb Zameer, John N Mariani, Jingya Zhang, Linnea Asp, Jimmy Huynh, Sean Mahase, Benjamin M Laitman, Azeb Tadesse Argaw, Nesanet Mitiku and 7 more

RetractedErratum issuedOpen access · greenAbstract read
In one paragraph

Article in Development (Cambridge, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Repair mechanisms of the central nervous system: From axon sprouting to remyelination.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Activins and Inhibins: Roles in Development, Physiology, and Disease.Cold Spring Harbor perspectives in biology · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Dipankar J DuttaNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Andleeb ZameerNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
John N MarianiNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Jingya ZhangNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Linnea AspNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Jimmy HuynhCorinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA Neuroscience, Mount Sinai School of Medicine, New York, NY 10029, USA.
Sean MahaseNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Benjamin M LaitmanNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Azeb Tadesse ArgawNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Nesanet MitikuNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Mateusz UrbanskiBiological Sciences, Hunter College, New York, NY 10065, USA.
Carmen V Melendez-VasquezBiological Sciences, Hunter College, New York, NY 10065, USA.
Patrizia CasacciaCorinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA Neuroscience, Mount Sinai School of Medicine, New York, NY 10029, USA.
Fernand HayotNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA Systems Biology, Mount Sinai School of Medicine, New York, NY 10029, USA.
Erwin P BottingerNephrology, Mount Sinai School of Medicine, New York, NY 10029, USA Charles Bronfman Institute for Personalized Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
Chester W BrownMolecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Gareth R JohnNeurology, Mount Sinai School of Medicine, New York, NY 10029, USA Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY 10029, USA gareth.john@mssm.edu.
Allen Institute for Brain Science · USIcahn School of Medicine at Mount Sinai · USHunter College · USBaylor College of Medicine · US

Funding

Basic and Translational Research Center for Reducing Health DisparitiesG12MD007599 · NIMHD · HUNTER COLLEGE · PI ANGULO, JESUS A · 2012 to 2017
$14.6M
Role and Mechanisms of Epithelial Injury in Diabetic NephropathyU01DK060995 · NIDDK · YESHIVA UNIVERSITY · PI BOTTINGER, ERWIN P. · 2001 to 2010
$6.0M
Role of cell cycle regulators in differentiationR01NS052738 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI CANOLL, PETER, CASACCIA, PATRIZIA · 2007 to 2020
$4.6M
Histone Deacetylation in Oligodendrocyte DifferentiationR37NS042925 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CASACCIA, PATRIZIA · 2012 to 2018
$4.3M
CYTOKINE SIGNALING IN RENAL FIBROSISR01DK056077 · NIDDK · YESHIVA UNIVERSITY · PI BOTTINGER, ERWIN P. · 1999 to 2009
$3.2M
Genetic Programming in Progressive Renal DiseaseR01DK060043 · NIDDK · YESHIVA UNIVERSITY · PI BOTTINGER, ERWIN P. · 2001 to 2010
$2.9M
Reactive astrogliosis regulates blood-brain barrier permeability.R01NS062703 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI JOHN, GARETH R · 2010 to 2017
$2.6M
Towards Molecular Diagnostics of Glomerular DiseaseR01DK073960 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BOTTINGER, ERWIN P. · 2006 to 2010
$1.6M
Kruppel-like factor-6 signaling in myelin formation and repairR01NS085103 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI JOHN, GARETH R · 2014 to 2017
$1.5M
Astrocyte regulation of CNS remyelinationR01NS056074 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI JOHN, GARETH R · 2008 to 2012
$1.4M
Regulation of myelination by myosin II-mediated mechanotransductionSC1NS000001 · NINDS · HUNTER COLLEGE · PI MELENDEZ-VASQUEZ, CARMEN V · 2013 to 2016
$1.4M
Advanced Microscopy Shared Resource FacilityR24CA095823 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FRIEDRICH, VICTOR LOUIS · 2002 to 2006
$1.3M
NCI NIH HHS R24 CA095823NCI NIH HHS R24CA095823NICHD NIH HHS R01HD01156NICHD NIH HHS R01HD27823NIDDK NIH HHS DK060043-S1NIDDK NIH HHS R01 DK056077NIDDK NIH HHS R01DK056077NIDDK NIH HHS R01 DK060043NIDDK NIH HHS R01DK060043NIDDK NIH HHS R01 DK073960NIDDK NIH HHS R01DK073960NIDDK NIH HHS U01 DK060995NIDDK NIH HHS U01DK060995NIMHD NIH HHS G12 MD007599NINDS NIH HHS R01 NS052738NINDS NIH HHS R01 NS056074NINDS NIH HHS R01NS056074NINDS NIH HHS R01 NS062703NINDS NIH HHS R01NS062703NINDS NIH HHS R01 NS085103NINDS NIH HHS R01NS52738NINDS NIH HHS R37 NS042925NINDS NIH HHS R37NS42925NINDS NIH HHS SC1 NS000001NINDS NIH HHS SC1NS000001
6 · The paper itself

Abstract

In the embryonic CNS, development of myelin-forming oligodendrocytes is limited by bone morphogenetic proteins, which constitute one arm of the transforming growth factor-β (Tgfβ) family and signal canonically via Smads 1/5/8. Tgfβ ligands and Activins comprise the other arm and signal via Smads 2/3, but their roles in oligodendrocyte development are incompletely characterized. Here, we report that Tgfβ ligands and activin B (ActB) act in concert in the mammalian spinal cord to promote oligodendrocyte generation and myelination. In mouse neural tube, newly specified oligodendrocyte progenitors (OLPs) are first exposed to Tgfβ ligands in isolation, then later in combination with ActB during maturation. In primary OLP cultures, Tgfβ1 and ActB differentially activate canonical Smad3 and non-canonical MAP kinase signaling. Both ligands enhance viability, and Tgfβ1 promotes proliferation while ActB supports maturation. Importantly, co-treatment strongly activates both signaling pathways, producing an additive effect on viability and enhancing both proliferation and differentiation such that mature oligodendrocyte numbers are substantially increased. Co-treatment promotes myelination in OLP-neuron co-cultures, and maturing oligodendrocytes in spinal cord white matter display strong Smad3 and MAP kinase activation. In spinal cords of ActB-deficient Inhbb(-/-) embryos, apoptosis in the oligodendrocyte lineage is increased and OLP numbers transiently reduced, but numbers, maturation and myelination recover during the first postnatal week. Smad3(-/-) mice display a more severe phenotype, including diminished viability and proliferation, persistently reduced mature and immature cell numbers, and delayed myelination. Collectively, these findings suggest that, in mammalian spinal cord, Tgfβ ligands and ActB together support oligodendrocyte development and myelin formation.

Indexed as

Gene Expression Regulation, DevelopmentalActivinsAnimalsCell AdhesionCell ProliferationCells, CulturedCell SurvivalCentral Nervous SystemCoculture TechniquesGene Expression ProfilingHumansLigandsMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, Knockoutactivin BActivinsLigandsSmad3 ProteinSmad3 protein, mouseTgfb1 protein, mouseTransforming Growth Factor beta1ActivinMyelinOligodendrocyteSmadTransforming growth factor

Identifiers

PMID24917498
PMCPMC4050697
OpenAlexW1970316010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.